Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $14,302 | 2 | 89.3% |
| Food and Beverage | $874.30 | 10 | 5.5% |
| Travel and Lodging | $837.89 | 5 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $12,123 | 3 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $2,250 | 1 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $953.72 | 7 | $0 (2024) |
| Travere Therapeutics, Inc. | $281.46 | 2 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $131.38 | 1 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $124.99 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $76.92 | 1 | $0 (2018) |
| GlaxoSmithKline, LLC. | $72.91 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,864 | 15 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($12,123) |
| 2022 | $72.91 | 1 | GlaxoSmithKline, LLC. ($72.91) |
| 2018 | $76.92 | 1 | Merck Sharp & Dohme Corporation ($76.92) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $119.83 | General |
| 10/23/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $161.63 | General |
| 10/08/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | TOLVAPTAN (Drug) | Food and Beverage | Cash or cash equivalent | $36.81 | General |
| Category: NEPHROLOGY | ||||||
| 10/08/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | TOLVAPTAN (Drug) | Travel and Lodging | Cash or cash equivalent | $34.00 | General |
| Category: NEPHROLOGY | ||||||
| 10/03/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | TOLVAPTAN (Drug) | Consulting Fee | Cash or cash equivalent | $12,052.00 | General |
| Category: NEPHROLOGY | ||||||
| 09/06/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| Category: Nephrology | ||||||
| 08/26/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Travel and Lodging | In-kind items and services | $303.97 | General |
| Category: NEPHROLOGY | ||||||
| 08/26/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $52.60 | General |
| Category: NEPHROLOGY | ||||||
| 08/26/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $43.78 | General |
| Category: NEPHROLOGY | ||||||
| 08/26/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Travel and Lodging | In-kind items and services | $38.99 | General |
| Category: NEPHROLOGY | ||||||
| 08/26/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Travel and Lodging | In-kind items and services | $30.48 | General |
| Category: NEPHROLOGY | ||||||
| 08/25/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Travel and Lodging | In-kind items and services | $430.45 | General |
| Category: NEPHROLOGY | ||||||
| 08/25/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $53.45 | General |
| Category: NEPHROLOGY | ||||||
| 06/17/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 06/13/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $131.38 | General |
| Category: CRITICAL CARE | ||||||
| 05/12/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $72.91 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2018 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $76.92 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 283 | 458 | $287,062 | $37,737 |
| 2022 | 12 | 275 | 374 | $391,569 | $39,302 |
| 2021 | 6 | 93 | 128 | $119,975 | $13,003 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 53 | 104 | $50,752 | $9,275 | 18.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 59 | 62 | $48,236 | $7,962 | 16.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 51 | 77 | $42,581 | $7,794 | 18.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 57 | 113 | $91,756 | $6,086 | 6.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 46 | $15,410 | $2,737 | 17.8% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 12 | 33 | $27,687 | $1,980 | 7.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $6,380 | $1,096 | 17.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 12 | $4,260 | $806.52 | 18.9% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 14 | 35 | $157,045 | $9,571 | 6.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 49 | 83 | $39,342 | $6,378 | 16.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 12 | 20 | $72,360 | $4,495 | 6.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 24 | $18,120 | $3,566 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 36 | 45 | $15,525 | $3,202 | 20.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 33 | 45 | $35,460 | $2,457 | 6.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 21 | 21 | $11,823 | $2,031 | 17.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 14 | 14 | $10,080 | $1,925 | 19.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 23 | 24 | $11,040 | $1,787 | 16.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 11 | 13 | $6,981 | $1,329 | 19.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 23 | 27 | $6,318 | $1,322 | 20.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 23 | $7,475 | $1,241 | 16.6% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 14 | 18 | $63,234 | $4,124 | 6.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 24 | 45 | $20,700 | $3,534 | 17.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 15 | $10,995 | $2,282 | 20.8% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 14 | 20 | $15,300 | $1,120 | 7.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 13 | 14 | $4,690 | $1,068 | 22.8% |
About Dr. Anna Gaddy, M.D
Dr. Anna Gaddy, M.D is a Nephrology healthcare provider based in Milwaukee, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2016. The National Provider Identifier (NPI) number assigned to this provider is 1619326980.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anna Gaddy, M.D has received a total of $16,014 in payments from pharmaceutical and medical device companies, with $15,864 received in 2024. These payments were reported across 17 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($14,302).
As a Medicare-enrolled provider, Gaddy has provided services to 651 Medicare beneficiaries, totaling 960 services with total Medicare billing of $90,042. Data is available for 3 years (2021–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Milwaukee, WI
- Active Since 06/08/2016
- Last Updated 06/21/2021
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1619326980
Products in Payments
- TOLVAPTAN (Drug) $12,123
- TARPEYO (Drug) $2,250
- JYNARQUE (Drug) $953.72
- TERLIVAZ (Drug) $131.38
- STEGLATRO (Drug) $76.92
- BENLYSTA (Biological) $72.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Milwaukee
Dr. Kevin Regner, M.d, M.D
Nephrology — Payments: $154,906
Dr. Manohar Ahuja, M.d, M.D
Nephrology — Payments: $32,239
Dr. Ahmed Malik, M.d, M.D
Nephrology — Payments: $15,742
Dr. Kevin Tucker, Md, MD
Nephrology — Payments: $7,904
Dr. Brahm Vasudev, Md, MD
Nephrology — Payments: $7,102
Dr. Samuel Blumenthal, Md, MD
Nephrology — Payments: $4,942